Unlike the other three kinases, studies have demonstrated that the PERK branch of the ISR has been shown to mitigate myocardial ischemia‐reperfusion injury and pathological cardiac hypertrophy,[24, 25] establishing its cardioprotective potential. This evidence concerns the gene EIF2AK3 and ischemia.